- Stocks
- Healthcare
- NASDAQ: AHCO

Price (delayed)

$25.72

Market cap

$3.45B

P/E Ratio

18.37

Dividend/share

N/A

EPS

$1.4

Enterprise value

$5.69B

AdaptHealth is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and

The EPS has surged by 163% year-on-year and by 25% since the previous quarter

The gross profit has surged by 114% year-on-year and by 5% since the previous quarter

AHCO's gross margin is up by 7% year-on-year but it is down by 3.8% since the previous quarter

The debt is up by 32% year-on-year

What are the main financial stats of AHCO

Market
Valuations
Earnings

Shares outstanding

134.29M

Market cap

$3.45B

Enterprise value

$5.69B

Price to earnings (P/E)

18.37

Price to book (P/B)

1.63

Price to sales (P/S)

1.29

EV/EBIT

16.74

EV/EBITDA

8.57

EV/Sales

2.12

Revenue

$2.68B

EBIT

$339.78M

EBITDA

$663.77M

Free cash flow

$78.87M

Per share
Balance sheet
Liquidity

EPS

$1.4

Free cash flow per share

$0.59

Book value per share

$15.8

Revenue per share

$19.99

TBVPS

$11.17

Total assets

$5.2B

Total liabilities

$3.08B

Debt

$2.35B

Equity

$2.12B

Working capital

$171.43M

Debt to equity

1.11

Current ratio

1.39

Quick ratio

1.1

Net debt/EBITDA

3.37

Margins
Efficiency
Dividend

EBITDA margin

24.8%

Gross margin

17.5%

Net margin

7.5%

Operating margin

9.8%

Return on assets

4%

Return on equity

10%

Return on invested capital

11.3%

Return on capital employed

7.1%

Return on sales

12.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the AdaptHealth stock price performed over time

Intraday

0.86%

1 week

15.34%

1 month

32.3%

1 year

1.78%

YTD

5.15%

QTD

42.57%

How have AdaptHealth's revenue and profit performed over time

Revenue

$2.68B

Gross profit

$469.27M

Operating income

$261.75M

Net income

$201.89M

Gross margin

17.5%

Net margin

7.5%

The net margin has soared by 177% year-on-year and by 17% since the previous quarter

The gross profit has surged by 114% year-on-year and by 5% since the previous quarter

AHCO's revenue has surged by 99% year-on-year and by 9% since the previous quarter

AdaptHealth's operating margin has surged by 69% YoY and by 7% QoQ

What is AdaptHealth's growth rate over time

What is AdaptHealth stock price valuation

P/E

18.37

P/B

1.63

P/S

1.29

EV/EBIT

16.74

EV/EBITDA

8.57

EV/Sales

2.12

The EPS has surged by 163% year-on-year and by 25% since the previous quarter

AHCO's equity is up by 18% year-on-year and by 2.6% since the previous quarter

AHCO's P/B is 9% higher than its last 4 quarters average of 1.5

AHCO's revenue has surged by 99% year-on-year and by 9% since the previous quarter

The stock's price to sales (P/S) is 8% less than its last 4 quarters average of 1.4

How efficient is AdaptHealth business performance

The ROA has soared by 166% YoY and by 25% QoQ

The company's return on equity has surged by 150% YoY and by 23% QoQ

The company's return on invested capital rose by 10% QoQ

The return on sales has grown by 9% since the previous quarter

What is AHCO's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for AHCO.

How did AdaptHealth financials performed over time

The total assets is 69% more than the total liabilities

AHCO's quick ratio is up by 43% year-on-year and by 8% since the previous quarter

The current ratio has increased by 42% year-on-year and by 3.7% since the previous quarter

The debt is 11% greater than the equity

The debt is up by 32% year-on-year

AHCO's equity is up by 18% year-on-year and by 2.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.